Titre:
  • Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986.
Auteur:De Santis, Maria; Bellmunt, Joaquim; Mead, Graham; Kerst, J Martijn; Leahy, Michael; Maroto, Pablo; Gil, Thierry; Marreaud, Sandrine; Daugaard, G; Skoneczna, I; Collette, Sandra; Lorent, Julie; de Wit, Ronald; Sylvester, Richard
Informations sur la publication:Journal of clinical oncology, 30, 2, page (191-199)
Statut de publication:Publié, 2012-01
Sujet CREF:Cancérologie
MeSH keywords:Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Carboplatin -- administration & dosage
Cisplatin -- contraindications
Deoxycytidine -- administration & dosage -- analogs & derivatives
Female
Humans
Male
Methotrexate -- administration & dosage
Middle Aged
Quality of Life
Questionnaires
Survival Rate
Urologic Neoplasms -- drug therapy
Vinblastine -- administration & dosage
Note générale:Clinical Trial, Phase II
Clinical Trial, Phase III
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0732-183X
info:doi/10.1200/JCO.2011.37.3571
info:pii/JCO.2011.37.3571
info:scp/84855583390
info:pmid/22162575
PMC3255563